Literature DB >> 8977318

Leishmania-infected macrophages sequester endogenously synthesized parasite antigens from presentation to CD4+ T cells.

P E Kima1, L Soong, C Chicharro, N H Ruddle, D McMahon-Pratt.   

Abstract

CD4+ T cell lines raised against the protective leishmanial antigens GP46 and P8 were used to study the presentation of endogenously synthesized Leishmania antigens by infected cells. Using two different sources of macrophages, the I4.07 macrophage cell line (H-2k) which constitutively expresses major histocompatibility complex (MHC) class II molecules, and elicited peritoneal exudate cells, we found that cells infected with Leishmania amastigotes presented little, if any endogenously synthesized parasite antigens to CD4+ T cells. In contrast, promastigote-infected macrophages did present endogenous parasite molecules to CD4+ T cells, although only for a limited time, with maximal presentation occurring within 24 h of infection and decreasing to minimal antigen presentation at 72 h post-infection. These observations suggest that once within the macrophage, Leishmania amastigote antigens are sequestered from the MHC class II pathway of antigen presentation. This allows live parasites to persist in infected hosts by evading the activation of CD4+ T cells, a major and critical anti-leishmanial component of the host immune system. Studies with drugs that modify fusion patterns of phagosomes suggest that the mechanism of this antigen sequestration includes targeted fusion of the parasitophorous vacuole with certain endocytic compartments.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8977318     DOI: 10.1002/eji.1830261249

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  24 in total

Review 1.  Beyond the classical: influenza virus and the elucidation of alternative MHC class II-restricted antigen processing pathways.

Authors:  Laurence C Eisenlohr; Nancy Luckashenak; Sebastien Apcher; Michael A Miller; Gomathinayagam Sinnathamby
Journal:  Immunol Res       Date:  2011-12       Impact factor: 2.829

2.  Delta-aminolevulinate-induced host-parasite porphyric disparity for selective photolysis of transgenic Leishmania in the phagolysosomes of mononuclear phagocytes: a potential novel platform for vaccine delivery.

Authors:  Sujoy Dutta; Celia Chang; Bala Krishna Kolli; Shigeru Sassa; Malik Yousef; Michael Showe; Louise Showe; Kwang-Poo Chang
Journal:  Eukaryot Cell       Date:  2012-02-03

3.  Designing therapies against experimental visceral leishmaniasis by modulating the membrane fluidity of antigen-presenting cells.

Authors:  Subha Banerjee; June Ghosh; Subha Sen; Rajan Guha; Ranjan Dhar; Moumita Ghosh; Sanchita Datta; Bikramjit Raychaudhury; Kshudiram Naskar; Arun Kumar Haldar; C S Lal; K Pandey; V N R Das; Pradeep Das; Syamal Roy
Journal:  Infect Immun       Date:  2009-03-16       Impact factor: 3.441

4.  Mechanisms of immune evasion in leishmaniasis.

Authors:  Gaurav Gupta; Steve Oghumu; Abhay R Satoskar
Journal:  Adv Appl Microbiol       Date:  2013       Impact factor: 5.086

5.  Transforming growth factor beta and immunosuppression in experimental visceral leishmaniasis.

Authors:  V Rodrigues; J Santana da Silva; A Campos-Neto
Journal:  Infect Immun       Date:  1998-03       Impact factor: 3.441

Review 6.  Subversion mechanisms by which Leishmania parasites can escape the host immune response: a signaling point of view.

Authors:  Martin Olivier; David J Gregory; Geneviève Forget
Journal:  Clin Microbiol Rev       Date:  2005-04       Impact factor: 26.132

7.  Biochemical and biological characterization of the protective Leishmania pifanoi amastigote antigen P-8.

Authors:  M Colmenares; M Tiemeyer; P Kima; D McMahon-Pratt
Journal:  Infect Immun       Date:  2001-11       Impact factor: 3.441

8.  Suboptimal Antigen Presentation Contributes to Virulence of Mycobacterium tuberculosis In Vivo.

Authors:  Patricia S Grace; Joel D Ernst
Journal:  J Immunol       Date:  2015-11-16       Impact factor: 5.422

Review 9.  Modulation of dendritic cell function by Leishmania parasites.

Authors:  Lynn Soong
Journal:  J Immunol       Date:  2008-04-01       Impact factor: 5.422

10.  CD4+ Th1 cells induced by dendritic cell-based immunotherapy in mice chronically infected with Leishmania amazonensis do not promote healing.

Authors:  Yannick F Vanloubbeeck; Amanda E Ramer; Fei Jie; Douglas E Jones
Journal:  Infect Immun       Date:  2004-08       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.